Gainers
Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
According to data from Benzinga Pro, during Q1, Nine Energy Service's (NYSE:NINE) reported sales totaled $116.94 million. Despite a 56.19% increase in earnings, the company posted a loss of $6.90 million.